Particle.news

Download on the App Store

Guidelines Tie Diet and Exercise to GLP-1 Drug Success as India Launches Treatments

JAMA Internal Medicine’s new protocol focuses on protein-rich meals with resistance training to sustain GLP-1–driven weight loss

Ozempic is medicine for adults with type 2 diabetes. Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient semaglutide, on January 13, 2025, in Sydney, Australia.
Image
Image

Overview

  • Semaglutide and tirzepatide therapies have just become available in India, sparking rising demand for medical weight-loss solutions.
  • The JAMA Internal Medicine guidance stresses that medication alone is insufficient and promotes tailored nutrition and physical activity to preserve muscle mass and improve adherence.
  • Nutrition recommendations include starting each meal with 20–30 grams of protein and aiming for 1.0–1.5 grams per kilogram of body weight daily to support lean tissue.
  • Experts outline dietary strategies to manage nausea, heartburn and constipation by choosing bland or fiber-rich foods, eating smaller portions and avoiding high-fat items.
  • The exercise plan advises a gradual build-up from 10 minutes of daily moderate activity to 150 minutes weekly, plus 30-minute resistance-training sessions two to three times per week.